Literature DB >> 528276

A comparison of the pharmacokinetics of multiple and single dose administrations of adriamycin.

D W Siemann, R M Sutherland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 528276     DOI： 10.1016/0360-3016(79)90652-7

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  8 in total

1.  Tissue distribution of doxorubicin and doxorubicinol in rats receiving multiple doses of doxorubicin.

Authors:  J H Peters; G R Gordon; D Kashiwase; E M Acton
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

2.  Mitigation of radiation-induced lung injury with EUK-207 and genistein: effects in adolescent rats.

Authors:  J Mahmood; S Jelveh; A Zaidi; S R Doctrow; R P Hill
Journal:  Radiat Res       Date:  2012-12-13       Impact factor: 2.841

3.  Varied effects of doxorubicin (DOX) on the corpus luteum of C57BL/6 mice during early pregnancy†.

Authors:  Christian Lee Andersen; Haeyeun Byun; Yuehuan Li; Shuo Xiao; Doris M Miller; Zidao Wang; Suvitha Viswanathan; Jonathan Matthew Hancock; Jaymie Bromfield; Xiaoqin Ye
Journal:  Biol Reprod       Date:  2021-12-20       Impact factor: 4.161

4.  Pharmacokinetics and disposition of 4'-O-tetrahydropyranyladriamycin in mice by HPLC analysis.

Authors:  H Iguchi; H Tone; T Ishikura; T Takeuchi; H Umezawa
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

5.  Doxorubicin pharmacokinetics after intravenous and intraperitoneal administration in the nude mouse.

Authors:  P B Johansen
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

6.  The response to cytotoxic drugs of EMT6 cells treated either as intact or disaggregated spheroids.

Authors:  T T Kwok; P R Twentyman
Journal:  Br J Cancer       Date:  1985-02       Impact factor: 7.640

7.  Renal and haemopoietic proliferative defects as a delayed consequence of cis-platin, adriamycin and daunomycin treatments.

Authors:  P G Braunschweiger; C J Kovacs; L L Schenken
Journal:  Br J Cancer       Date:  1982-03       Impact factor: 7.640

8.  In vivo tumour-cell proliferation after adriamycin treatment.

Authors:  R Rowley; H A Hopkins; W B Looney
Journal:  Br J Cancer       Date:  1982-03       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.